Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Winnick

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Neurology International|June 2, 2021
Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)Amnon A Berger, Emily R Sottosanti, Ariel Winnick, et al.
Psychopharmacology Bulletin|February 26, 2021
Lasmiditan for the Treatment of Migraines With or Without Aura in AdultsAmnon A Berger, Ariel Winnick, Daniel Popovsky, et al.
Psychopharmacology Bulletin|March 28, 2022
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)Amnon A Berger, Emily R Sottosanti, Ariel Winnick, et al.
Clinical Drug Investigation|December 22, 2021
Opicapone for the Treatment of Parkinson's Disease "Off" Episodes: Pharmacology and Clinical ConsiderationsAmnon A Berger, Christopher Robinson, Ariel Winnick, et al.
Health Psychology Research|July 1, 2022
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" EpisodesAmnon A Berger, Ariel Winnick, Jonathan Izygon, et al.
Health Psychology Research|October 20, 2022
Rimegepant for the treatment of migraineAmnon A Berger, Ariel Winnick, Austin H Carroll, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Neurology International|June 2, 2021
Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS)Amnon A Berger, Emily R Sottosanti, Ariel Winnick, et al.
Psychopharmacology Bulletin|February 26, 2021
Lasmiditan for the Treatment of Migraines With or Without Aura in AdultsAmnon A Berger, Ariel Winnick, Daniel Popovsky, et al.
Psychopharmacology Bulletin|March 28, 2022
Suvorexant in the Treatment of Difficulty Falling and Staying Asleep (Insomnia)Amnon A Berger, Emily R Sottosanti, Ariel Winnick, et al.
Clinical Drug Investigation|December 22, 2021
Opicapone for the Treatment of Parkinson's Disease "Off" Episodes: Pharmacology and Clinical ConsiderationsAmnon A Berger, Christopher Robinson, Ariel Winnick, et al.
Health Psychology Research|July 1, 2022
Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" EpisodesAmnon A Berger, Ariel Winnick, Jonathan Izygon, et al.
Health Psychology Research|October 20, 2022
Rimegepant for the treatment of migraineAmnon A Berger, Ariel Winnick, Austin H Carroll, et al.
Pageof 2